HOME >> BIOLOGY >> NEWS
Potential new treatment for Gaucher disease developed by scientists at Scripps Research Institute

A group of scientists at The Scripps Research Institute (TSRI) have developed a compound that could potentially be used as a new treatment for Gaucher disease, the most common genetic disorder affecting Jewish people of Eastern European ancestry. Although not tested in humans, the compound has shown great promise in human cell lines cultured from patients who suffer from the disease.

Patients with Gaucher disease may bruise easily due to low blood platelets, and they may have enlargement of the liver and spleen. Sometimes they experience fatigue due to anemia. The disease also causes cells in the bone marrow to become engorged with a fatty storage material, which may lead to bone lesions, weakening the skeleton, and sometimes resulting in painful fractures. In some instances, the disease also impairs the function of the lungs.

In an article that will be published in an upcoming issue of the journal Proceedings of the National Academy of Sciences, the TSRI group describes using small molecules to partially correct the genetic defect that underlies most cases of Gaucher disease. The defect prevents a crucial metabolic enzyme from reaching the location in the cell where it normally functions, but the small molecules act as "chaperones," guiding the mutant enzyme to the right location and allowing it to survive and function.

"This is an entirely new approach to the disease," says TSRI Professor Ernest Beutler, M.D., who is one of the authors of the study and one of the world's leading experts on Gaucher disease and similar metabolic disorders. Beutler's laboratory was the first to clone the gene responsible for Gaucher disease in the mid-1980s.

"And it may be less costly and more convenient than the current treatment," adds Jeffrey W. Kelly, who is the Lita Annenberg Hazen Professor of Chemistry and vice president of academic affairs at TSRI. Kelly led the research effort along with the study's first author, Anu Sawkar, a Ph.D. student in
'"/>

Contact: Jason Bardi
jbardi@scripps.edu
858-784-9254
Scripps Research Institute
4-Nov-2002


Page: 1 2 3 4

Related biology news :

1. Potential for enhanced sequestration of carbon in soils supports evaluations
2. Potential blood test for colon cancer risk
3. Potential cause of arthritis discovered
4. Potential of regenerative medicine explored
5. Potential therapy reported for children, adults with end-stage liver disease
6. Potential allergy vaccine boosts hope for sufferers
7. Potential of tailoring drugs to genetic makeup confirmed--but challenges remain
8. Potential new anthrax therapy discovered
9. Potential gene therapy carriers created that mimic viruses, without the risk
10. New Class Of Synthetic Capsules That Mimic Biological Cells Has Wide Array Of Potential Uses
11. Role Of Protein Linked To Colon Cancer Identified, Offering Potential Target For Therapy

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/4/2020)... ... March 04, 2020 , ... ... CEOs to apply to the MedTech IGNITE program’s 2020 IGNITE Cohort. The MedTech ... curriculum to attract and nurture the next generation of medtech founders and entrepreneurs. ...
(Date:3/2/2020)... ... ... Toronto-based clinical research organization (CRO) and regulatory consulting firm, dicentra , ... south of Clarksburg on a farm on Beaver Valley Road. , The owners currently ... and decided it would be a great new option for employees to relocate to. ...
(Date:2/28/2020)... ... February 26, 2020 , ... ... PRF® devices are now available to veterinary practices through Covetrus. Enso Discoveries ... will provide the most affordable, easiest to use, multi-species validated, platelet-rich plasma ...
Breaking Biology News(10 mins):
(Date:2/21/2020)... ... February 20, 2020 , ... The ... chemistry. Humans have been increasingly successful in innovating ways to engineer these ... technologies and strategies for modern molecular biology (e.g., gene sequencing, writing, and ...
(Date:2/21/2020)... ... , ... Pharmaceutical manufacturers are under increasing pressure to fast-track ... approaches like ‘Industry 4.0’ and continuous manufacturing, combat the growing and intense competition ... with an industry with the world’s tightest regulations and complex value chains, what ...
(Date:2/19/2020)... ... February 19, 2020 , ... Red Nucleus, a leading ... today announced the opening of a new office in Tokyo, Japan. The new ... Red Nucleus announced the new office in response to customer requests for regional ...
(Date:2/11/2020)... ... 2020 , ... Synagro Technologies, Inc. , the preeminent ... the City of Fort Worth has partnered with Synagro of Texas-CDR (Synagro) to ... 2020, Synagro will assume operation of the city’s current biosolids management facility and ...
Breaking Biology Technology:
Cached News: